Determining corporate citizenship, which dictates jurisdiction, has divided district court judges, leading the U.S. Court of Appeals for the Third Circuit to hear a case brought by "thalidomide babies" against GlaxoSmithKline on an expedited basis since the legitimate location of GSK Holdings’ principal place of business is in dispute.
GSK argues that it is a citizen of Delaware, allowing for diversity jurisdiction in federal court. The plaintiffs argue that it is a citizen of Pennsylvania, requiring the case to be remanded to the Philadelphia Court of Common Pleas.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
